Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation

Blood Purification

Volumn 34, Issue 3-4, 2013, Pages 290-297

  Sjöberg, Bodil ^a   Qureshi, A Rashid ^a   Anderstam, Björn ^a   Alvestrand, Anders ^a   Bárány, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biocompatibility; Cardiovascular disease; Hemodialysis; Inflammation; Pentraxin

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PENTRAXIN 3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIALYSIS MEMBRANE; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN SECRETION;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HEMODIAFILTRATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; SERUM AMYLOID P-COMPONENT; TIME FACTORS;

EID: 84870743430     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000342630     Document Type: Article

References (38)

1. Foley R, Parfrey P, Sarnak M: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112-S119. (Pubitemid 28527268)
2. Himmelfarb J, Hakim R: Oxidative stress in uremia. Curr Opin Nephrol Hypertens 2003; 12: 593-598. (Pubitemid 38186749)
3. Stenvinkel P: Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton) 2006; 11: 36-41.
4. Gutierrez A, Alvestrand A, Wahren J, Bergström J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990; 38: 487-494. (Pubitemid 20258752)
5. Caglar K, Peng Y, Pupim L, Flakoll P, Levenhagen D, Hakim R, Ikizler T: Inflammatory signals associated with hemodialysis. Kidney Int 2002; 62: 1408-1416.
6. Kaysen GA, Dubin JA, Müller HG, Rosales LM, Levin NW: The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int 2000; 58: 346-352. (Pubitemid 30429881)
7. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, Bergstrom J: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002; 13(suppl 1):S28-S36.
8. Yeun J, Levine R, Mantadilok V, Kaysen G: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000; 35: 469-476. (Pubitemid 30124077)
9. Snaedal S, Heimbürger O, Qureshi A, Danielsson A, Wikström B, Fellström B, Fehrman- Ekholm I, Carrero J, Alvestrand A, Stenvinkel P, Bárány P: Comorbidity and acute clinical events as determinants of c-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kidney Dis 2009; 53: 1024-1033.
10. Tong M, Carrero J, Qureshi A, Anderstam B, Heimbürger O, Bárány P, Axelsson J, Alvestrand A, Stenvinkel P, Lindholm B, Suliman M: Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2007; 2: 889-897.
11. Breviario F, d'Aniello E, Golay J, Peri G, Bottazzi B, Bairoch A, Saccone S, Marzella R, Predazzi V, Rocchi M: Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to c-reactive protein and serum amyloid p component. J Biol Chem 1992; 267: 22190-22197.
12. Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, Spreafico F, Pausa M, D'Ettorre C, Gianazza E, Tagliabue A, Salmona M, Tedesco F, Introna M, Mantovani A: Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins c-reactive protein and serum amyloid P component. J Biol Chem 1997; 272: 32817-32823. (Pubitemid 28023616)
13. Alles V, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A: Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 1994; 84: 3483-3493. (Pubitemid 24352913)
14. Latini R, Maggioni A, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A, Investigators LATINL: Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004; 110: 2349-2354. (Pubitemid 39407338)
15. Bussolati B, Peri G, Salvidio G, Verzola D, Mantovani A, Camussi G: The long pentraxin PTX3 is synthesized in iga glomerulonephritis and activates mesangial cells. J Immunol 2003; 170: 1466-1472. (Pubitemid 36139516)
16. Jaillon S, Peri G, Delneste Y, Frémaux I, Doni A, Moalli F, Garlanda C, Romani L, Gascan H, Bellocchio S, Bozza S, Cassatella M, Jeannin P, Mantovani A: The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007; 204: 793-804. (Pubitemid 46631609)
17. Mantovani A, Garlanda C, Bottazzi B, Peri G, Doni A, Martinez de la Torre Y, Latini R: The long pentraxin PTX3 in vascular pathology. Vascul Pharmacol 2006; 45: 326-330. (Pubitemid 44765293)
18. Taskinen S, Hyvönen M, Kovanen P, Meri S, Pentikäinen M: C-reactive protein binds to the 3beta-OH group of cholesterol in LDL particles. Biochem Biophys Res Commun 2005; 329: 1208-1216. (Pubitemid 40568699)
19. Klouche M, Peri G, Knabbe C, Eckstein H, Schmid F, Schmitz G, Mantovani A: Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis 2004; 175: 221-228. (Pubitemid 38942901)
20. Nauta A, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble W, Gingras A, Tzima S, Vivanco F, Egido J, Tijsma O, Hack E, Daha M, Roos A: Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol 2003; 33: 465-473. (Pubitemid 36267612)
21. Miyaki A, Maeda S, Otsuki T, Ajisaka R: Plasma pentraxin 3 concentration increases in endurance-trained men. Med Sci Sports Exerc 2011; 43: 12-17.
22. Juutilainen A, Vänskä M, Pulkki K, Hämäläinen S, Nousiainen T, Jantunen E, Koivula I: Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy. Eur J Haematol 2011; 87: 441-447.
23. He X, Han B, Liu M: Long pentraxin 3 in pulmonary infection and acute lung injury. Am J Physiol Lung Cell Mol Physiol 2007; 292:L1039-L1049. (Pubitemid 47084848)
24. Tong M, Anderstam B, Sjoberg B, Alvestrand A: Circulating levels of long pentraxin 3 (PTX3) are elevated in hemodialysis patients and increase acutely after a single HD session (abstract). J Am Soc Nephrol 2006; 17: 735A.
25. Suliman M, Qureshi A, Carrero J, Bárány P, Yilmaz M, Snaedal-Jonsdottir S, Alvestrand A, Heimbürger O, Lindholm B, Stenvinkel P: The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. QJM 2008; 101: 397-405. (Pubitemid 351619248)
26. Bergström J, Wehle B: No change in corrected beta 2-microglobulin concentration after cuprophane haemodialysis. Lancet 1987; 1: 628-629. (Pubitemid 17024248)
27. Suliman M, Yilmaz M, Carrero J, Qureshi A, Saglam M, Ipcioglu O, Yenicesu M, Tong M, Heimbürger O, Barany P, Alvestrand A, Lindholm B, Stenvinkel P: Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 976-985.
28. Kerr PG, Huang L: Review: membranes for haemodialysis. Nephrology (Carlton) 2010; 15: 381-385.
29. Nockher W, Scherberich J: Monocyte cellsurface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS. Kidney Int 1995; 48: 1469-1476.
30. Raj DS, Carrero JJ, Shah VO, Qureshi AR, Barany P, Heimburger O, Lindholm B, Ferguson J, Moseley PL, Stenvinkel P: Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. Am J Kidney Dis 2009; 54: 1072-1080.
31. Wiedermann C, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F, Willeit J: Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck study. J Am Coll Cardiol 1999; 34: 1975-1981. (Pubitemid 30002653)
32. Pereira B, Snodgrass B, Hogan P, King A: Diffusive and convective transfer of cytokine- inducing bacterial products across hemodialysis membranes. Kidney Int 1995; 47: 603-610.
33. Oldani S, Finazzi S, Bottazzi B, Garlanda C, Baldassarre E, Valaperta S, Cuccovillo I, Albini M, Child M, Montanelli A, Graziani G, Badalamenti S: Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients. J Nephrol 2012; 25: 120-126.
34. Boehme M, Kaehne F, Kuehne A, Bernhardt W, Schroder M, Pommer W, Fischer C, Becker H, Muller C, Schindler R: Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease. Nephrol Dial Transplant 2007; 22: 2224-2229. (Pubitemid 47244700)
35. Malaponte G, Libra M, Bevelacqua Y, Merito P, Fatuzzo P, Rapisarda F, Cristina M, Na selli G, Stivala F, Mazzarino M, Castellino P: Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines. Int J Mol Med 2007; 20: 471-481.
36. Koulouridis E, Tzilianos M, Katsarou A, Costimba I, Klonou E, Panagiotaki E, Georgalidis C, Krokida A, Delaportas N, Lachanas A, Karaliotas G, Kaliolia I: Homocysteine and c-reactive protein levels in haemodialysis patients. Int Urol Nephrol 2001; 33: 207-215. (Pubitemid 34575368)
37. Park C, Shin Y, Kim C, Lee S, Yu S, Kim S, Choi E, Chang Y, Bang B: Increased c-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis 2002; 40: 1230-1239. (Pubitemid 35403135)
38. Chiang CK, Huang JW, Hsu SP, Ho TI, Pai MF, Peng YS, Liu SH, Hung KY, Tsai TJ: Plasma interleukin-18 levels in hemodialysis patients: increased by dialysis process and association with interleukin-6 and tumor necrotic factor-alpha. Blood Purif 2006; 24: 174-179.